OUR PORTFOLIO

Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.

All Filters

Clear
Clear
Clear
Clear
Clear
Clear
Clear
Investigator: Douglas Galasko

2 Projects | 1 Researchers | $265,000 Invested

2019

University of California, San Diego

Douglas Galasko, MD

TABLOOD: a biomarker panel for direct assessment in blood of Alzheimer’s Disease pathophysiological hallmarks.

  • Funding Amount: $125,000
  • Organization Type: Academic/Nonprofit
  • Program: Diagnostics Accelerator
  • Target: Tau
  • Status: Closed

2012

University of California, San Diego

Douglas Galasko, MD

Development of synaptic biomarkers related to AMPA-receptor trafficking in Alzheimer's Disease

  • Funding Amount: $140,000
  • Organization Type: Academic/Nonprofit
  • Program: Clinical
  • Target: Synaptic Activity and Neurotransmitters
  • Status: Closed